Metal-removing therapy may help some heart patients-study
November 5th, 2012
By Deena Beasley and Bill Berkrot LOS ANGELES | Sun Nov 4, 2012 7:36pm EST LOS ANGELES (Reuters) – A controversial therapy to remove heavy metals from the bloodstream was shown in a large trial to cut the risk of another major heart problem in patients who have already suffered a heart attack, but researchers cautioned that the benefit was small and more study is needed. Chelation therapy, an alternative treatment dismissed by many medical professionals as quackery, has its origins in unproven 50-year-old theories about the cause of arterial plaques, the fatty deposits that can cause heart attacks.
Sanofi considered moving headquarters abroad: report
November 4th, 2012
PARIS | Sun Nov 4, 2012 11:04am EST PARIS (Reuters) – Sanofi’s management considered moving its headquarters abroad in the last few months but the plan was nixed by the drugmaker’s chairman, French weekly Le Journal du Dimanche reported on Sunday, citing sources close to the board. First mooted in July, when the Socialist government was preparing to introduce a 75 percent tax on top earnings, the plan envisaged moving the headquarters to London or the United States, or at least relocating Chief Executive Chris Viehbacher and his closest associates abroad
GSK raises bet on AIDS drug with new Shionogi deal
October 29th, 2012
Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. GlaxoSmithKline announce their half yearly results on Wednesday July 23. Credit: Reuters/Toby Melville By Ben Hirschler and Mayumi Negishi LONDON/TOKYO | Mon Oct 29, 2012 7:03am EDT LONDON/TOKYO (Reuters) – GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan’s Shionogi which gives it a much bigger economic interest in the new product
Landmark Medicare settlement could change lives
October 27th, 2012
U.S. Health and Human Services Secretary Kathleen Sebelius and the FDA’s Margaret Hamburg announce new tobacco package labelling, in the Brady Press Briefing Room of the White House in Washington, June 21, 2011. Credit: Reuters/Jason Reed By Mark Miller CHICAGO | Sat Oct 27, 2012 2:56pm EDT CHICAGO (Reuters) – Glenda Jimmo has had a challenging life.
Israeli medical device offers new Alzheimer’s treatment
October 24th, 2012
By Tova Cohen TEL AVIV | Wed Oct 24, 2012 8:06am EDT TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer’s disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014
For a full-body workout, drumming is the novelty to beat
October 22nd, 2012
By Dorene Internicola NEW YORK | Mon Oct 22, 2012 5:05am EDT NEW YORK (Reuters) – Drumsticks, pounded on gym floors, clinked overhead and bounced on exercise balls, are among the latest workout tools to tap into the group fitness scene, according to fitness experts. Drumming classes do more than conjure dreams of rock glory.
Coca-Cola, Sanofi team for new line of "Beautific" drinks
October 16th, 2012
Tue Oct 16, 2012 5:26pm EDT (Reuters) – U.S. soft drink company Coca-Cola Co is teaming up with French drugmaker Sanofi to launch a line of drinks in France that will claim to aid health and beauty. The partnership calls for the co-development and distribution of drinks under the Oenobiol “Beautific” brand, a Coca-Cola spokesman said
Mother’s fish, mercury intake tied to kids’ ADHD risk: study
October 9th, 2012
Tue Oct 9, 2012 5:16am EDT (Reuters) – Children’s risk of developing attention-deficit/hyperactivity disorder (ADHD) later in life may be tied to how much fish their mothers ate while pregnant, according to a U.S.